Home › Forums › Infexion Connexion › M.chimaera in cardiothoracic heater cooler units – FDA moves to halt shipping from device manufacturer linked to patient deaths
- This topic has 0 replies, 1 voice, and was last updated 8 years, 10 months ago by Glenys Harrington.
-
AuthorPosts
-
11/01/2016 at 9:04 pm #72665Glenys HarringtonParticipant
Author:
Glenys HarringtonEmail:
infexion@ozemail.com.auOrganisation:
Infection Control Consultancy (ICC)State:
Dear All,
For those following the issue of cardiothoracic heater cooler units this
article from Beckers Infection Control & Clinical Quality and FDA warning
letter (following inspection at manufacturing plants) may be of interest.“FDA moves to halt shipping from device manufacturer linked to patient
deathsThe Food and Drug Administration
has issued a warning letter to LivaNova, a London-based medical device
manufacturer, stating the company does not provide adequate cleaning
information to prevent bacteria from accumulating inside its heater-cooler
machines, which were linked to deaths at
WellSpan York (Pa.) Hospital in October and
Penn State Hershey Medical Center in November. Between the two
hospitals, 3,600 patients were notified that they may be at risk from
infections due to the devices.The heater-cooler devices, used during open heart surgery to regulate
temperature, never come into contact with patients. However, the machines
are at risk of accumulating biofilm, which contains harmful bacteria that
can be transmitted to patients through the air during surgery. Between Penn
State Hershey Medical Center and WellSpan York Hospital, at least six deaths
have been linked to the devices. In addition to finding the
manufacturer-issued device-cleaning protocol to be ineffective, the FDA’s
investigation revealed the devices were misbranded and the company was
operating without an approved application for pre-market approval”.Beckers Infection Control & Clinical Quality – Written by Max Green |
January 06, 2016http://www.beckershospitalreview.com/quality/fda-to-halts-shipping-from-devi
ce-manufacturer-linked-to-4-deaths.htmlFDA Warning Letter
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2015/ucm479684.ht
mLivaNova PLC Provides Update on FDA Warning Letter – LONDON, Jan. 05, 2016
http://www.livanova.com/investor-relations/pressreleases/news_release_212642
9regards
Glenys
Glenys Harrington
Consultant
Infection Control Consultancy (ICC)
PO Box 5202
Middle Park
Victoria, 3206
Australia
M: +61 404 816 434
ABN 47533508426
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
-
AuthorPosts
- The forum ‘Infexion Connexion’ is closed to new topics and replies.